Liver microwave ablation: a systematic review of various FDA-approved systems

Research output: Contribution to journalReview articlepeer-review

20 Citations (Scopus)
304 Downloads (Pure)

Abstract

ObjectivesThe aim of the present study is to analyze preclinical and clinical data on the performance of the currently US Food and Drug Administration (FDA)-approved microwave ablation (MWA) systems.MethodsA review of the literature, published between January 1, 2005, and December 31, 2016, on seven FDA-approved MWA systems, was conducted. Ratio of ablation zone volume to applied energy R(AZ:E) and sphericity indices were calculated for ex vivo and in vivo experiments.ResultsThirty-four studies with ex vivo, in vivo, and clinical data were summarized. In total, 14 studies reporting data on ablation zone volume and applied energy were included for comparison R(AZ:E). A significant correlation between volume and energy was found for the ex vivo experiments (r=0.85, p

Original languageEnglish
Pages (from-to)4026-4035
Number of pages10
JournalEuropean Radiology
Volume29
Issue number8
Early online date30-Nov-2018
DOIs
Publication statusPublished - Aug-2019

Keywords

  • Microwaves
  • Ablation techniques
  • Electromagnetic radiation
  • Tumor volume
  • Liver diseases
  • EX-VIVO BOVINE
  • VENOUS-BLOOD FLOW
  • IN-VIVO
  • THERMOSPHERE ABLATION
  • HEPATOCELLULAR-CARCINOMA
  • RADIOFREQUENCY ABLATION
  • REPORTING CRITERIA
  • THERMAL ABLATION
  • DEVICES
  • ENERGY

Cite this